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Crosslinker-modified nucleic acid probes
for improved target identification and
biomarker detection
Joke Elskens and Annemieke Madder *
Understanding the intricate interaction pattern of nucleic acids with other molecules is essential to gain
further insight in biological processes and disease mechanisms. To this end, a multitude of hybridization-
based assays have been designed that rely on the non-covalent recognition between complementary
nucleic acid sequences. However, the ephemeral nature of these interactions complicates straightforward
analysis as low efficiency and specificity are rule rather than exception. By covalently locking nucleic acid
interactions by means of a crosslinking agent, the overall efficiency, specificity and selectivity of
hybridization-based assays could be increased. In this mini-review we highlight methodologies that exploit
the use of crosslinker-modified nucleic acid probes for interstrand nucleic acid crosslinking with the
objective to study, detect and identify important targets as well as nucleic acid sequences that can be
considered relevant biomarkers. We emphasize on the usefulness and advantages of crosslinking agents
and elaborate on the chemistry behind the crosslinking reactions they induce.
1. Introduction
Nucleic acids such as deoxyribonucleic acid (DNA) and ribonucleic
acid (RNA), are key regulators in living organisms. DNA, the holder
of the genetic information, directs biological processes via
transcription into messenger RNA (mRNA), which serves as tem-
plate for the translation into proteins. This theory, known as the
central dogma of molecular biology, states that information flows
from nucleic acids to proteins.1 Originally, RNA was considered a
helper molecule, serving the main purpose of assisting and
controlling the processes involved in protein synthesis. As only
3% of the total human genome codes for proteins, researchers in
the field wondered what the function of the remaining non-coding
portion could be. Certain housekeeping RNAs like transfer or
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ribosomal RNAs were known to be expressed and to be important
for normal cell functioning, but they could not account for all non-
protein coding sequences in the genome. It was only with the
discovery of regulatory non-coding RNAs (ncRNA) that the impor-
tance of these non-coding regions started to be revealed.2 These
ncRNAs are not constitutively expressed in cells and exert their
regulatory function by forming highly ordered dynamic struc-
tures capable of interacting with DNA, RNA and proteins. They
are subdivided based on their length into small or long ncRNAs.
Small regulatory ncRNAs (o200 nucleotides) include the small
interfering RNAs (siRNA), the piwi-interacting RNAs and the
micro-RNAs (miRNA). These ncRNAs act as key regulators of
gene expression (e.g. miRNAs are involved in regulating mRNA
levels) and their mode of action is quite well understood.2 The
long non-coding RNAs (lncRNA), with a length over 200 nucleo-
tides, are the most numerous but least comprehended regulatory
RNAs to date. It is estimated that more than 16 000 lncRNAs
exist, while currently only the function of approximately 50
lncRNAs is understood.3 They are involved in transcriptional4-
and epigenetic regulation,5 in controlling mRNA stability6 and
function as miRNA sponges.7 For many years, the function of
RNA as regulatory unit was underestimated and to this day, just
a tip of its full potential has been uncovered. Considering
their role in regulating biological processes, further insight in
ncRNA function is pivotal. To achieve this, identification of the
ncRNA interaction partners (e.g. proteins and other nucleic
acids) is of major importance. For this purpose, different
hybridization-based technologies such as ChiRP (chromatin
isolation by RNA purification),8 CHART (capture hybridization
analysis of RNA targets),9 immunoprecipitation (IP)10 assays and
variants thereof have been developed. These assays use
nucleic acid capture probes to isolate and analyse ncRNA
complexes and merely differ in buffer conditions and capture
probe design.†
Besides regulating biological processes, nucleic acids also
control pathological pathways and can consequently be considered
as relevant biomarkers for e.g. cancer,11,12 neurodegenerative-13,14
and infectious diseases.15 For example, studies indicated that the
expression levels of certain mRNAs and ncRNAs correlate with
disease manifestation.3,16,17 On the other hand, typical DNA bio-
markers arise from variations occurring at the genomic level which
include single nucleotide polymorphisms (SNP) and short tandem
sequences to name a few.18 Additionally, epigenetically modified
nucleic acids containing methylation or hydroxymethylation sites
can also serve as biomarkers, as they control gene silencing and
gene overexpression.19 Indeed, the methylation pattern in DNA has
been correlated with diseases such as cancer.20 In addition to
chromosomal DNA, mitochondrial or pathogenic DNA sequences
can also be considered as biomarkers.21,22
Nucleic acid biomarker detection and target identification
assays such as the above-mentioned ChiRP, CHART and IP
assays, are often based on the non-covalent hybridization of an
oligonucleotide capture probe recognizing its complementary
DNA or RNA target (Fig. 1A).18,23,24 The transient nature of this
hybridization-based interaction hampers the overall efficiency
as target sequences are often lost during work-up. While a
series of bifunctional, externally added crosslinking agents are
available and could be used to reinforce the non-covalent
interactions for better complex stability during work-up, most
of these show little selectivity in terms of the exact site of
covalent connection between the strands in a complex. In a very
elegant approach, Kool et al. were able to achieve site-specific
crosslinking using their so-called BINARI probes (bis-nicotinic
azide reversible interaction) for trapping RNA–RNA interac-
tions.25 In this set-up, the inherently reactive bifunctional agent
is used for site-selective simultaneous acylation of 20OH groups
of opposing non-complementary RNA sequences located at a
specific distance from a short complementary region within the
RNA–RNA complex. It is clear that the above-mentioned assays
could further benefit from nucleic acid capture probes modified
with a crosslinking agent to achieve site-specific crosslinking in a
broader context. Upon hybridization of the crosslinker-modified
nucleic acid probe with its target oligonucleotide, a covalent
linkage is introduced between both, rendering the interaction
irreversible (Fig. 1B). This ensures that a maximal amount of
target is retained throughout the assay, even when stringent
washing conditions are applied. The latter is beneficial for
increasing the assay’s specificity and selectivity as non-specific
interactions can be easily washed away during work-up. This
however necessitates careful design of the crosslinker modified
capture probes. Indeed, the conditions required for crosslinking
and the covalent linkage formed upon reaction may not interfere
with downstream processes such as PCR and MS to ensure
accurate detection with high sensitivity.
Considering their importance and contribution in unravelling
the biology of cells, we describe in this review a series of meth-
odologies that exploit the use of crosslinker-modified nucleic acid
probes for interstrand nucleic acid crosslinking with the objective
to study, detect and identify important targets as well as nucleic
acid sequences that can be considered relevant biomarkers.
Fig. 1 Difference between a non-covalent hybridization assay (A) and a
covalent hybridization assay (B).
† The term crosslinking is often used in the context of these hybridization-based
assays but refers to the cell fixation in which oligonucleotide sequences and their
interaction partners are covalently locked in a random fashion. In the current
review, the term crosslinking refers to the introduction of a site-specific covalent
link between a capture probe and its complementary nucleic acid target.
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Furthermore, we elaborate on the chemistry of the crosslink
reactions. The discussed crosslinking agents can be divided into
three categories: (1) photoactivatable crosslinking agents; (2) cross-
linking probes activated by chemical agents; (3) oligonucleotides
containing abasic sites as inherently reactive crosslinking agents.
Table 1 provides a summary of the discussed agents and their key
features.
2. Photo-activatable crosslinking
agents for target identification and
biomarker detection
2.1 Coumarin
The first class of crosslinking agents requires light to initiate the
crosslink reaction. Light activation imposes some advantages
over other activation methods as it allows spatiotemporal control
of the reaction. If needed, the light beam can be directed to a
specific area and irradiation can be halted and resumed at any
time. Examples of photo-activatable crosslinking agents include
coumarin derivatives, psoralen, vinylcarbazoles, 4-thiouridines
and diazirines.
Coumarin-based crosslinkers are able to photo-crosslink to
nearby thymine bases via a [2+2] cycloaddition reaction upon
irradiation at 350 nm, yielding predominantly the syn-
cycloaddition adduct. Photo-reversibility is achieved when a
wavelength of 254 nm is employed (Fig. 2A). Coumarins have
mainly been used as medicines (e.g. warfarin26) or as fluorophores
for biomolecule labeling. Therefore, multiple coumarin variants
have been designed to date (Fig. 2B).27–32
A specific application of coumarin derivatives in the context
of biomarker identification can be found in the NAXCOR assay.
This hybridization-based diagnostic test exploits a 7-hydroxy-
coumarin derivative for photo-crosslinking and is used for the
Table 1 Overview of the different crosslinking agents discussed in this review and their key features
Crosslinker
Activation
mode Reaction type Reversible Target Target base & position Biological applications
In vivo/
in vitro
Coumarin UV, 350 nm [2+2] Yes,
254 nm
DNA T SNP detection In vitro
Base should oppose the crosslinker Detection and quantification of
viral DNA
DNA methylation
Psoralen UV, 365 nm [2+2] Yes,
254 nm
DNA,
RNA
C, T, U SNP detection In vitro
Base should oppose the crosslinker Antisense In vivo
Identification of miRNA targets
(miR-TRAP, miR-CLIP)
DNA methylation
Vinylcarbazole: [2+2] Yes,
312 nm
DNA,
RNA
C, T, U Antisense In vitro
CNVK UV, 365 nm Base should be located at position
1 in the complementary strand
DNA methylation In vivo
CNVD UV, 365 nm Detection and identification of
miRNA targets
PCX VIS, 400 nm FISH
SNP detection
4-Thiouridines UV, 365 nm [2+2] No DNA,
RNA
C RNA target identification In vitro
Base should oppose the crosslinker
Diazirines UV, 365 nm Carbene No DNA,
RNA
A, C, G, T Identification of miRNA targets In vitro
Reaction with nearby nucleophiles,
predominantly with base opposing
the crosslinker
Phenylselenide Dual
activation mode:
No DNA A
Base should oppose the crosslinker
SNP detection In vitro
– UV, 350 nm Radical
– Chemical
(1O2, NaIO4)
Michael type
reaction
Furan Chemical
activation:
No DNA,
RNA
A, C
Base should oppose the crosslinker
Detection of DNA and RNA targets In vitro
– 1O2 [4+2]
– NBS Nucleophilic
addition
Abasic site Inherently
reactive
Nucleophilic
addition
No DNA A: positioned one nucleotide closer
to the 30 site of the complementary
strand
SNP detection In vitro
G: positioned one nucleotide closer
to the 50 site of the complementary
strand
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detection of the factor V leiden mutation, a G to A single
nucleotide mutation in the factor V gene and the most common
inherited risk for thrombosis (Fig. 3A).33 Individuals are either
homozygotes (two normal or two mutant factor V alleles) or
heterozygotes (one copy of the normal and mutant allele).
This diagnostic assay combines the use of coumarin modified
reporter probes and capture probes for detection (yellow in
Fig. 3A) and recognition (purple in Fig. 3A) respectively. A total
of six reporter probes is used, each modified with two coumarin
crosslinking moieties and two fluorescein labels. These reporter
probes are complementary to non-allele specific regions of exon
10 and intron 10 of the factor V gene, thereby flanking the
capture probe binding site. The capture probe is an allele-
specific 16-mer oligonucleotide modified with both coumarin
and biotin that is able to hybridize at the mutation site in the
factor V gene. Upon incubation, the reporter (yellow) and capture
probes (purple) hybridize with the factor V gene (blue). This is
followed by crosslink formation and streptavidin pull-down, with
the latter separating crosslinked probes from their non-
crosslinked counterparts. Next, detection of crosslinked product
is achieved by incubating the samples with anti-fluorescein
antibodies labelled with alkaline phosphatase. Addition of a
suitable fluorescent enzyme substrate generates a colored pro-
duct with an intensity that correlates to the concentration of
fluorescein in the sample. Discrimination between normal or
mutant alleles (both homo- or heterozygotic) is achieved by using
a three-fold analysis system, where each sample is subjected to
different probe sets. Each probe set contains the same six
fluorescein modified reporter probes but differs in the used
capture probe – the capture probe is either fully complementary
to the normal gene (set 1) or the mutated gene (set 2). Alter-
natively, the probe set contains both the normal and the mutant
capture probe (set 3). Assay conditions were optimized in such a
way that hybridization and crosslinking with mismatched
sequences is minimized. Consequently, the intensity of the
fluorescent read-out is dependent on the used probe set and
the presence or absence of the factor V leiden mutation. For
individuals with normal alleles, the fluorescent intensity will be
maximal when the normal or mixed capture probe sets are used
(set 1 and 3) and the lowest with capture probes complementary
to the mutant alleles (set 2). The opposite is true for individuals
with the factor V leiden mutation. Hence, single nucleotide
polymorphism detection in this NAXCOR assay is solely based
on a difference in hybridization and crosslinking efficiency of
two distinct capture probes, which in turn results in a change in
fluorescent read-out. Besides detection of single nucleotide
polymorphisms, the detection and quantification of viral
DNA34 as well as the assessment of gene dosage and methylation
status has also been described.35
After the initial report, a variant of the NAXCOR assay was
published with improved sensitivity and signal to noise ratio
(Fig. 3B).36 While the general principle remains the same, the
optimized assay differs from the original assay in two distinct
features: (1) the reporter probes (yellow) are modified with a
polyamine tail allowing the coupling of approximately 10 times
more fluorescein moieties. This in turn significantly enhanced
the signal generation capacity and enhanced the signal to
noise ratio; (2) instead of crosslinking the capture probe
directly to the target sequence, an indirect 3-probe approach
was opted for. Herein, the capture probe (red) is positioned
between, and covalently connected to two adjacent flanking
probes (green), by means of crosslink formation between the
overhanging partially complementary regions of the capture
and flanking probes (Fig. 3B). The flanking probes are further
responsible for crosslinking to the target. This indirect cross-
linking approach resulted in a 2.8-fold improvement in sensi-
tivity and enhanced the applicability of the NAXCOR assay for
SNP detection.
Fig. 2 (A) Mechanism of the [2+2] cycloaddition reaction between coumarin
and thymine. (B) Examples of coumarin derivatives. 7-Hydroxycoumarin is
used as crosslinking agent in the NAXCOR assay.
Fig. 3 (A) Illustration of the NAXCOR assay. Fluorescein modified reporter
probes (yellow) and biotinylated capture probes (purple) are crosslinked to
the factor V leiden gene (blue). (B) Variant of the NAXCOR assay in which
reporter probes (yellow) are modified with a tail of fluorescein molecules.
The biotinylated capture probe (red) is indirectly crosslinked to the factor
V leiden gene (blue) by means of crosslinker-modified flanking probes
(green).
Review RSC Chemical Biology
O
pe
n 
A
cc
es
s 
A
rt
ic
le
. P
ub
lis
he
d 
on
 2
2 
Fe
br
ua
ry
 2
02
1.
 D
ow
nl
oa
de
d 
on
 6
/8
/2
02
1 
4:
01
:2
0 
PM
. 
 T
hi
s 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
C
om
m
on
s 
A
ttr
ib
ut
io
n-
N
on
C
om
m
er
ci
al
 3
.0
 U
np
or
te
d 
L
ic
en
ce
.
View Article Online
414 |  RSC Chem. Biol., 2021, 2, 410–422 © 2021 The Author(s). Published by the Royal Society of Chemistry
2.2 Psoralen
Psoralen and derivatives thereof belong to the family of furocou-
marins and are characterised by a planar tricyclic structure that
allows intercalation in any AT or AU region of double stranded
DNA and RNA sequences respectively. Upon irradiation with long
wavelength UV-A (365 nm), psoralens are able to react via a [2+2]
cycloaddition reaction with the C5–C6 bond of pyrimidines
(Fig. 4A), either via their furan or pyrone photoreactive site,
which results in the formation of a cyclobutane adduct. Hence,
one psoralen moiety is able to react with two different pyrimidine
residues in a regio- and stereoselective manner as only the cis–syn
products are formed. The syn nomenclature refers to the position-
ing of the N1 amine of the pyrimidine bases relative to the C2 of the
pyrone or the O10 of the furan moiety. In the syn product, these are
located on adjacent corners of the cyclobutene ring (Fig. 4A). The cis
configuration indicates the position of the psoralen compared to
the pyridimine base. After photo-crosslinking, both are located on
the same side of the cyclobutane ring.37,38 This photo-reaction can
be reversed by controlling the irradiation wavelength.39
Psoralens can also be incorporated in oligonucleotide
sequences to allow sequence-specific photo-crosslinking. For
this purpose, different psoralen-modified nucleosides have
been designed (Fig. 4B).40–47 These constructs have been applied
for crosslinking triplex forming oligonucleotides to double
stranded DNA44,47 and, although not yet translated into therapeutic
applications, psoralens have been used in the conceptual design of
crosslinking antisense oligonucleotides.40,42,48
Psoralen-modified oligonucleotides are also used in the
context of biomarker detection. More specifically, Yamayoshi
et al. confirmed, in a proof-of-concept study, the utility of
psoralen in the discrimination of C5-methylated cytosine
from non-methylated cytosine bases in DNA.41 Cytosine
C5-methylation–demethylation is involved in the epigenetic regula-
tion of gene expression and determination of the position and
frequency of methylation provides crucial information to under-
stand this process. Psoralen crosslinking proved up to 5-fold higher
with C5-methyl cytosine compared to demethylated cytosine, in
single as well as in double stranded DNA, thus allowing to
discriminate between the two modifications. The same research
group also tested the ability of 20 psoralen modified deoxyadeno-
sine residues to identify a G - T single nucleotide polymorphisms
in the H-ras gene.43 Discrimination between the mutant and wild
type form is based on the observed pyrimidine selectivity of
psoralen crosslinking. As such, crosslinking proceeded in moder-
ate yield with the mutant H-ras gene while almost no crosslinking
was observed with the wild type. However, while promising, this
method would benefit from improved crosslinking efficiencies,
which requires careful design of the linker connecting the psoralen
moiety to the sugar ring of deoxyadenosine.
Psoralens have also been intensively used for the in vivo
identification of miRNA targets. In cells, processed miRNAs
carry out their function by forming a miRNA–protein complex
with Argonaute proteins resulting in the RNA induced silencing
complex (RISC). This RISC complex directs the miRNA to
complementary mRNAs, resulting in degradation of the latter
and gene silencing. The miR-TRAP strategy (miRNA-target RNA
affinity purification), was developed for the direct identification
of miRNA targets, thereby avoiding the use of antibodies typically
employed in classical immunoprecipitation strategies.49 The
miR-TRAP strategy exploits the recognition of miRNAs by the
Argonaute proteins and uses psoralen-modified miRNAs for
photo-crosslinking of miRNA–RNA complexes. These miRNAs
are 30-biotinylated and after crosslinking of the biotinylated
miRNA probes to their targets, the complexes are isolated via
streptavidin pull-down and analysed via reverse transcription
quantitative polymerase chain reaction (RT-qPCR). Photo-
crosslinking resulted in a 4 to 20-fold enrichment of miRNA
targets and facilitated the identification of downregulated or
repressed miRNA targets. An alternative strategy for the identifi-
cation of miRNA targets was developed by Hall et al., and relies on
miRNA crosslinking in combination with immunoprecipitation.50
Their strategy, called miR-CLIP (miRNA crosslinking and immu-
noprecipitation), was tested with the miRNA-106a, which is a
psoralen- and biotin-modified miRNA mimic. Upon transfection
of the miRNA-106a probe into HeLa cells and subsequent photo-
crosslinking, the complexes were purified via Argonaute-based
immunoprecipitation. Subsequently, the RNA was isolated and
miRNA-target complexes were further purified via streptavidin
affinity purification. During this step only miRNA crosslinked
targets are isolated. Analysis via deep sequencing identified
hundreds of targets, with amongst them the H19 lncRNA which
is involved in cell proliferation51 and is regarded as an important
cancer biomarker.52 These examples illustrate the benefit of
crosslinker-based strategies in applications such as SNP detection
and miRNA target identification even if, in the discussed exam-
ples, the authors did not provide any comparative data as to the
Fig. 4 (A) Upon irradiation with UV-A (365 nm), psoralens react via a [2+2]
cycloaddition reaction with nearby pyrimidine residues. The reaction can
be reversed upon irradiation with a shorter wavelength (254 nm). The
mechanism is depicted for the reaction with thymine bases. The cyclobutane
product is highlighted in blue and the syn-adduct is shown. A schematic
representation of the cis-configuration is also given. (B) Examples of psoralen
derivatives incorporated in oligonucleotide sequences.
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pull-down efficiency of the crosslinker-based strategy versus that of
the non-covalent counterpart.
2.3 Vinylcarbazole-based crosslink agents
Psoralens have been demonstrated to be thymine selective
photo-crosslinkers (vide supra). However, the necessity for an
AT or AU region restricts their general applicability. Moreover,
the short wavelength UV-irradiation (254 nm) required for the
photo-reversibility results in the formation of pyrimidine
dimers, a common type of DNA damage. To circumvent these
drawbacks, Fujimoto and co-workers reported on the synthesis
of a 3-cyanovinylcarbazole nucleoside (CNVK) as a novel photo-
activatable crosslinking agent for site-specific intermolecular
nucleic acid crosslinking.53 This agent is selectively activated by
short exposure to long-wavelength UV-A light (366 nm) and
possesses higher photo-reactivity compared to psoralens.
Indeed, the crosslinking reaction with thymidine was reported
to proceed at 97% yield upon 1 second of photo-irradiation.
Moreover, the reversible nature of the crosslink reaction at
312 nm irradiation was confirmed and shown to proceed with-
out DNA damage. Molecular modelling studies indicated that
the vinyl group of the CNVK moiety is stacked onto the C5–C6
double bond of pyrimidine nucleobases located at the 1
position on the complementary strand. This allows the photo-
chemical [2+2] cycloaddition reaction to take place (Fig. 5).
Kinetic, thermodynamic and NMR structural analysis indicated
that the photo-crosslinking reaction with thymine proceeds via
the trans-isomer of CNVK, yielding one single photoadduct.54
This ultrafast nucleic acid crosslinking strategy proved to be
clean, high-yielding and controllable in terms of selectivity and
reversibility. Moreover, its biocompatibility was demonstrated
both in vitro and in vivo (vide infra). Throughout the past years,
variants of the CNVK moiety have been designed that operate via
a similar [2+2] cycloaddition mechanism. For example, the
pyranovinylcarbazole derivative PCX was developed (Fig. 6),
which could be selectively activated by visible light irradiation
(400 nm).55 Substitution of the rigid deoxyribose sugar in CNVK
and PCX with a more flexible D-threoninol linker was also
explored. The use of this modified building block allows
increasing the crosslinking reaction rate substantially as the
increased flexibility introduced by the D-threoninol linker minimizes
entropic loss during hybridization (Fig. 6).56–58
From a practical point of view, CNVK crosslinkers have been
used in the design of shielded covalent probes. These are
nucleic acid hairpin structures containing a single stranded
tail sequence and a crosslinking moiety in their stem region
(Fig. 7A).59 In the presence of a complementary DNA or RNA
target, hybridization between the target and the tail sequence
(step A) triggers the unfolding of the hairpin structure and
results in probe-target binding (step B). After complete hybridiza-
tion (step B), selective crosslinking to the target can be initiated
using UV-A irradiation, thereby locking the probe-target inter-
action (step C). By optimizing the length of the single stranded
tail, efficient mismatch discrimination could be achieved, even for
SNP detection. The observed high selectivity is a consequence of
the conformational change imposed by the probe-target binding
event. Indeed, any mismatch destabilizes the probe–target
complex and favours the non-target-bound hairpin structure. CNVK
crosslinkers were also used in a pull-down experiment for the
identification of miR-29b targets, a miRNA involved in e.g.
apoptosis and cell differentiation.60 In this assay, miR-29b
Fig. 5 Mechanism of the photo-crosslinking reaction between 3-
cyanovinylcarbazole (CNVK) and thymine (T) upon UV-A irradiation
(366 nm). Photo-reversibility of the crosslinking reaction can be achieved
by irradiating the product at 312 nm.
Fig. 6 Structure of 3-cyanovinylcarbazole (CNVK), pyranocarbazole (PCX)
and 3-cyanovinylcarbazole with D-threoninol linker.
Fig. 7 (A) Principle of the shielded covalent probe approach. Upon
hybridization of a DNA or RNA target with the probe’s tail sequence (step
A), the hairpin structure unfolds (step B). After complete hybridization, the
probe-target interaction can be locked by initiation of the crosslink
reaction (step C). Figure reprinted (adapted) with permission from J. Am. Chem.
Soc., 2013, 135, 26, 9691–9699 (https://pubs.acs.org/doi/10.1021/ja4009216),
further permission related to the material excerpted should be directed to ACS.
(B) Principle of the molecular beacon approach applied in the fluorescence
in situ hybridization assays. Cy3 = cyanine fluorophore, Dabcyl = quencher,
X = CNVK or PCX crosslinker moiety. Figure reprinted (adapted) from K. Fujimoto,
M. Hashimoto, N. Watanabe and S. Nakamura, Bioorganic Med. Chem. Lett.,
2019, 29, 2173–2177, Copyright (2020) with permission from Elsevier.
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mimics were employed that contained both biotin and CNVK
moieties. Addition of the CNVK modified miR-29b mimics to intact
or lysed mouse and human cell lines, successfully induced complex
formation with the endogenous Argonoute 2 complex present in
these cells, with no observed cytotoxicity. Isolation of the complex
then allowed the identification of both known and novel miR-29b
targets. By employing the CNVK probes, a 3.9 to 20-fold enrichment
was achieved compared to the non-crosslink-based method.
Both CNVK and PCX crosslinkers have been used in wash-free
fluorescence in situ hybridization assays (FISH). This metho-
dology is commonly employed for investigating the location of
nucleic acids in cells.61,62 In the here described application, a
molecular beacon modified at the 50 end with a fluorophore
(e.g. Cy3) and at the 30 end with a quencher (e.g. dabcyl) is used
(Fig. 7B). Prior to target binding, fluorophore and quencher are
in close proximity to each other, which suppresses the fluorescent
signal. Upon target binding, the beacon unfolds, which in turn
increases the distance between the fluorophore and quencher. As
a result, the fluorescent signal is switched on. The probe-RNA
interaction can subsequently be locked through photo-irradiation
of the crosslinker moiety. CNVK and PCX modified molecular
beacons have been applied for the visualisation of E. coli 26S
rRNA in fixed and living cells respectively (Fig. 7B). The fast photo-
crosslinking reaction allowed targeting RNA molecules with
complex secondary structures and improved the detection sensitivity
of the assay. An additional advantage of the molecular beacon
approach is that washing steps can be omitted. Applications of
cyanovinyl-based crosslinkers are not limited to the examples given
above. Indeed, these fascinating constructs have paved their way in
applications such as 19F-NMR based detection of nucleic acid
sequences,63 in DNA-peptide photo-crosslinking,64 in DNA
assemblies65 and in antisense applications66,67 to name a few.
2.4 4-Thiouridines
Within the realm of photo-activatable crosslinking agents,
4-thiouridines have not received the same attention as
vinylcarbazole-based crosslinkers. The photo-reactive proper-
ties of these uridine analogues are obtained by replacing the
carbonyl oxygen at position 4 by a sulphur atom rendering
them capable of forming adducts with nucleobases and amino
acids. Upon UV irradiation at 365 nm, 4-thiouridines react with
nearby cytosines via a [2+2] cycloaddition reaction (Fig. 8).68,69
The unstable thietane intermediate formed, ring opens with
concomitant formation of a stable covalent bond. Contrary to
previous photo-activatable crosslinkers, this reaction is irrever-
sible. 4-Thiouridines are easily incorporated into RNA sequences
with minimal distortion due to their small size and retained base
pairing ability. Consequently, they have been used in the identifi-
cation of protein–RNA interactions‡ (e.g. in immunoprecipita-
tion approaches70), and RNA–nucleic acid interactions. For
example, binding of miRNA-10a to the 5’ untranslated region
of ribosomal protein mRNAs was discovered by employing
4-thiouridine crosslinking in combination with streptavidin
affinity purification.71
2.5 Diazirines
A last example of photo-activatable crosslinking agents concerns the
diazirines. Unlike aforementioned photo-crosslinkers, diazirines do
not react via a [2+2] cycloaddition mechanism. Instead, irradia-
tion with UV-A light generates a reactive carbene intermediate,
which is capable of reacting with a variety of chemical groups,
even unreactive C–H bonds (Fig. 9).
Diazirine crosslinking has been used for interstrand cross-
linking of nucleic acids and to study nucleic acid–protein or
protein–protein interactions. It should therefore not come as a
surprise that throughout the years a plethora of diazirine
analogues have been developed and synthesized for this
purpose.72–76 Diazirines possess certain properties which ren-
ders them superior compared to other existing (photo)-
crosslinking methods in certain applications. For instance,
the long wavelength UV-A photo-irradiation minimizes
UV-mediated damage in biological systems and although other
crosslinkers exist that allow remediating this problem (vide
supra), the small nature of diazirines minimizes steric hindrance
compared to its contesters. Furthermore, the stable C–C bonds
formed upon crosslinking accounts for the robustness of this
methodology. The high-reactivity of carbenes and their ability to
react with all 4 nucleobases (A, C, G, T/U) makes them ideal for
the identification of unknown nucleic acid targets (e.g. miRNA
targets).73 Nakamoto et al. investigated the use of RNA probes
modified with 3-phenyl-3-trifluoromethyl-3H-diazirines for capturing
miRNA targets. In a first proof-of-concept study, they substituted
the nucleobases of ribonucleosides with a trifluoromethyl dia-
zirine moiety, which was connected via an acetal linkage to the
sugar ring. This was followed by testing the efficiency and gene
silencing ability of these analogues.77 Having obtained satisfactory
results, the authors assessed the applicability of the most
promising photo-reactive diazirine moiety for the labelling of
mRNA targets in living cells.78 The model system of choice was
Fig. 8 Mechanism for the reaction between 4-thiouridines (4-ThioU) and
cytosine (C).
Fig. 9 Mechanism of diazirine activation shown for a 3-phenyl-3-
trifluoromethyl-3H-diazirine derivative.
‡ Thiouridines are expected to interact with lysine, tyrosine, tryptophane, methio-
nine and cysteine residues. Although thiouridines are commonly applied for
locking nucleic acid–protein interactions, the exact nature of the formed photo-
adducts and the mechanism of the photo-reaction is not very-well understood.
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the miRNA-145, which targets the known mRNAs FSCN1 and
KLF4. Transfection of dual crosslinker- and biotin-modified
miRNA probes in DLD-1 cancer cells, followed by subsequent
photo-crosslinking, streptavidin purification and quantification
of the isolated crosslinked product, showed an enhanced enrich-
ment of the FSCN1 and KLF4 mRNA targets with the crosslinker-
modified probes compared to the unmodified control probes.
This illustrates the applicability of diazirine crosslinkers for the
labelling and targeting of miRNAs targets. In 2018, an alkyne-
modified diazirine nucleoside was designed for the development
of tag-free miRNA probes.79 Biotinylation of miRNAs hampers
efficient RISC loading and consequently interferes with mRNA
targeting.72 By introducing the biotin moiety after photo-
crosslinking, here achieved via a copper catalysed azide–alkyne
cycloaddition reaction (CuAAC) between the alkyne modified
diazirine nucleoside and the azide-modified biotin moiety, the
degree of RISC-loading was increased. Moreover, these alkyne-
modified miRNAs showed comparable gene silencing abilities as
their unmodified counterparts. As such, this strategy could be
potentially useful for the identification of unknown miRNA targets.
3. Crosslinking probes activated by
chemical agents
3.1 Phenyl selenide
In general, light-controlled activation of crosslinking agents repre-
sents a green and biocompatible strategy, which is often applied in a
biological context. However, when irradiation with short wavelength
UV is required, UV-mediated damage is often observed and an
undesirable side effect. Additionally, the efficiency of photo-
activation depends on the transparency of the sample and the
limited penetration depth of UV- or visible light would hamper
photo-activation in turbid samples or in tissues. Crosslinking probes
activated by chemical agents might offer a solution in this context.
A first example of crosslinking agents that are activated by
chemical means encompasses phenyl selenides. These intrinsic
unreactive probes can be activated via photo-irradiation or
through the addition of an oxidant (e.g. singlet oxygen 1O2 or
sodium periodate NaIO4).
80,81 In the case of oxidative activation,
the phenyl selenide is converted into a selenoxide (Fig. 10, step a),
Fig. 10 (A) Mechanism of the oxidative activation (top) and photo-irradiation (bottom) of the phenyl selenide-modified thymidine (PhSe-dT) and
subsequent reaction with an opposing deoxyadenosine (dA). (a) NaIO4 or
1O2 (b) [2,3]-sigmatropic rearrangement (c) photo-irradiation (d) Reaction with
N1 amine of dA (e) isomerisation. (B) Structure of bifunctional phenyl selenide-modified phenol derivatives and phenyl selenide-modified pyrimidine
nucleobases. PhSe-dT = phenyl selenide-modified 20-deoxythymidine; PhSe-5-Me-dC = phenyl selenide-modified 5-methyl-20-deoxycytidine.
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which reacts further via a [2,3] sigmatropic rearrangement (step b).
The formed methide species acts as a powerful Michael-acceptor
and reacts with the N1 amine of purine nucleobases (step c). In the
case of adenine alkylation, the formed N1 crosslinked adduct
isomerizes further to the more stable N6-adduct (step d).82 Alter-
natively, when photo-irradiation is employed to activate the phenyl
selenide, a radical intermediate is formed (Fig. 10, step a0) which
is capable of alkylating the N1 position of purine bases. To explore
the utility of phenyl selenides in crosslinking applications, multi-
ple analogues have been developed either as bifunctional
phenols83 or as modified pyrimidine nucleobases80,82 (Fig. 10B).
The major advantage of the latter is their compatibility with solid
phase DNA synthesis. Phenyl selenide analogues have been
applied for single nucleotide discrimination in plasmid DNA.84
In this assay, biotinylated oligonucleotide probes containing a
phenyl selenide-modified 20-deoxythymidine moiety (PhSe-dT)
were crosslinked to target DNA sequences. The formed adducts
were subsequently detected using a fluorescent reporter assay
based on an avidin-horseradish peroxidase conjugate. The target
sequence was codon 248 in exon 7 of the p53 gene, which is often
prone to G - A mutations in human cancer. This methodology
allowed the discrimination of single nucleotide mismatches
with an efficiency of 193 : 1. Moreover, the target DNA could be
detected in the low nanomolar range without the need for PCR
amplification.
3.2 Furan
The major advantage of phenyl selenides is their dual mode of
activation in which one can choose the chemical or photo-
irradiation approach depending on the application. In our
research group, probes benefitting from a similar dual mode
of activation were developed based on furan as a masked
reactive moiety. The idea to use furan as reactive group is
inspired by the intrinsic reactivity of this molecule in the body.
Indeed, oxidation of furan by cytochrome P450 leads to a highly
electrophilic di-aldehyde that can react with diverse nucleophiles
such as those present on amino acid side chains or nucleic acid
bases. From an experimental point of view, furan activation can
be achieved chemically via oxidation with N-bromo-succinimide
or via a photo-activation strategy. The latter employs singlet
oxygen as oxidant, which is produced upon visible light irradia-
tion of a suitable photosensitizer. The generated singlet oxygen
induces furan oxidation through a [4+2] cycloaddition reaction
with concomitant formation of the corresponding endoperoxide
(Fig. 11A). Hydrolysis of this intermediate followed by elimina-
tion of the hydrogen peroxide anion yields the 4-oxo-2-enal
moiety.85 The natural occurrence of singlet oxygen in biological
systems and the possibility to perform singlet oxygen mediated
reactions in aqueous solutions renders this approach biocompa-
tible and green. Furthermore, the need for furan activation
guarantees spatiotemporal control. Indeed, as the irradiation
position, intensity and frequency can be varied, local activation
of furan can be achieved without affecting non-target tissue
or cells.
For nucleic acid interstrand crosslinking, hybridization of a
furan-modified oligonucleotide with its complementary strand
brings both reaction partners in close proximity. The base-pair
complementarity needed for hybridization is responsible for
the sequence selectivity of the system. Subsequent activation of
the furan by singlet oxygen triggers reaction with an opposing
adenine or cytosine base in the complementary strand, resulting
in crosslink formation. The proximity-dependence of this reaction
and the possibility for visible light activation makes this a
selective, attractive and biocompatible crosslinking methodology.
Hence, it should not come as a surprise that different furan
derivatives have been developed (Fig. 11B) and that the furan-
based crosslinking strategy has been successfully implemented for
interstrand nucleic acid crosslinking,85–88 PNA crosslinking,89,90
crosslinking of DNA and RNA with proteins91 and crosslinking of
peptides with proteins.92 Recently, furan-PNA probes were used in
a diagnostic context for the detection of 22-mer DNA or RNA
targets. This assay is based on the templated ligation of a furan
modified PNA strand, immobilized on a surface, and a PNA strand
modified with a photosensitizer and a nucleophilic moiety. The
photosensitizer enables local singlet oxygen production, while the
nucleophile is capable of reacting with the furan warhead. Liga-
tion between both PNA strands is obtained upon furan activation
with visible light, but only occurs in presence of a complementary
oligonucleotide target serving as template for both strands
(Fig. 12). Only upon ligation, a read-out is obtained. This
templated set-up enables selective enzyme-free detection of
oligonucleotide sequences, and is potentially valuable for the
detection of miRNA targets.90 Moreover, this furan-oxidation
based methodology is currently under investigation for the
development of an improved ChiRP assay for the in vitro identifi-
cation of long non-coding RNA targets. Classical ChiRP experi-
ments typically rely on the non-covalent hybridization of a series
of biotinylated capture probes to their complementary sequences
on a ncRNA target, followed by biotin–streptavidin pull-down.
The aim is to isolate the ncRNA and identify its relevant
interaction partners. Unfortunately, this strategy suffers from
low selectivity and efficiency, partly due to the non-covalent
nature of the interaction between capture probe and ncRNA
target. By covalently fixing this interaction through activation of
a furan crosslinker, more selective and higher yielding in vitro
ncRNA target identification should become possible. Recent
Fig. 11 (A) Mechanism of furan activation via reaction with singlet oxygen.
(B) Examples of furan crosslinkers incorporated in oligonucleotide sequences.
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studies in our group focus on the use of furan crosslinking-
enhanced enrichment of lncRNA sequences in vitro.
4. Oligonucleotides containing abasic
sites as inherently reactive crosslinking
agents
Among the methodologies at hand, furan-oxidation based
crosslinking is not the only one inspired by a naturally occurring
process. Abasic sites (AP), also referred to as apurinic or apyrimi-
dinic sites (Fig. 13), are one of the most occurring types of DNA
damage. They are generally formed upon hydrolysis of the glyco-
sidic bond connecting the nucleobase with the sugar backbone in
nucleotides, but can also be generated upon exposure to radiation,
anticancer drugs or mutagens.93 AP sites exist in two forms that
are in equilibrium with each other, namely the cyclic hemiacetal
form and the ring-opened aldehyde form (Fig. 13). Their reactivity
is inherently linked to the electrophilic nature of the aldehyde,
which makes them prone to react with nearby nucleophiles.
Consequently, AP sites are highly mutagenic as they can introduce
crosslinks in duplex DNA, which might hinder replication, tran-
scription or the cellular repair mechanisms. Moreover, abasic sites
lack the heterocyclic purine or pyrimidine bases that form stabi-
lizing hydrogen bonding interactions upon base-pairing, which
results in destabilization of the DNA duplex.93,94
The inherent reactivity of AP sites has inspired researchers
to exploit this moiety for interstrand oligonucleotide cross-
linking. Consequently, methods compatible with solid phase
DNA synthesis, have been developed for the generation of
abasic sites in oligonucleotides. For example, AP sites can be
generated upon reaction of 20-deoxyuridine with the enzyme
uracil DNA glycosylase (UDP), through periodate oxidation of a
vicinal diol or upon irradiation of a photolabile o-nitrobenzyl
acetal.95 Sequences containing abasic sites have been employed
as crosslinking agents for the detection of single nucleotide
polymorphisms. Gates et al. designed AP probes targeting a
T - A mutation at position 1799 in the human BRAF kinase
gene.96 The AP sites haven proven to be reactive towards the N6
exocyclic amino group of 20-deoxyadenosine, when positioned
one nucleotide closer to the 30 site of the opposing strand
(Fig. 14A).97 Probes fully complementary to the wildtype
sequence and modified with an abasic site, successfully
discriminated between the wildtype and the mutant gene, with
crosslinking yields up to 83% for the latter and no detectable
yields for the wildtype. The flexibility induced by the mismatch
in the mutant gene is most likely responsible for the selectivity
of the reaction and for the observed yield. Detection of the
crosslinked product and hence the SNP, has been performed
via a variety of methods such as fluorescent, colorimetric or
electrochemical detection. Additionally, a nanopore detection
strategy was developed based on an a-hemolysin ion channel
which is capable of capturing nucleic acid structures when
subjected to an electric potential.96 The measured read-out is
significantly different for crosslinked duplexes compared to
their non-crosslinked counterparts, thus allowing the efficient
detection of the mutant genes (in this case the BRAF gene).
A similar strategy was employed for targeting the cancer driven
C - G mutation at position 35 in the human KRAS gene.98
Reaction between the N2-exocyclic amine of 2-deoxyguanosine
and the abasic site proceeds via the formation of an imine
intermediate, which can be reduced with NaCNBH3 to form a
stable covalent linkage (Fig. 14B). In contrast to 20-deoxyadenosine
crosslinking, the AP site should be located one nucleotide closer
to the 50 site of the opposing strand. This discrepancy is a
Fig. 13 Equilibrium between the cyclic hemiacetal form and the ring-opened
aldehyde form of the abasic site.
Fig. 12 Principle of the templated ligation of two PNA strands: a furan
modified PNA strand (blue) and a PNA strand (purple), dually modified with
a nucleophile (Nu) and a photosensitizer (PS). Ligation is only observed
upon hybridization with an oligonucleotide target (black strand).
Fig. 14 Mechanism of crosslink formation between the abasic site on one
oligonucleotide strand and the N6-exocyclic amine of 20-deoxyadenosine
(A) or the N2-exocyclic amine of 2-deoxyguanosine (B) on the opposite
strand.
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consequence of the position of the exocyclic amine within a DNA
duplex (major groove for adenine vs. minor groove for guanine).97
Interestingly, AP probes introducing non-canonical structures
such as loops and bulges drastically increase the yield of the
crosslinking reaction, most likely due to the increased flexibility.98
Overall, abasic sites offer elegant and efficient possibilities for
interstrand nucleic acid crosslinking and have proven useful for
SNP detection. The ease of incorporating AP precursors in DNA
sequences via solid phase synthesis, the efficiency of abasic site
generation and the compatibility of the resulting AP probes with
different detection strategies, have paved the way for further
exploration of such crosslinking agents in biology-related
applications.
5. Conclusion
Hybridization-based assays are standard practice when it comes to
the study and detection of nucleic acids and their interaction
partners. These assays are crucial for gaining insight in biological
processes but suffer from limited affinity and selectivity. The
transient nature of nucleic acid interactions and the reversibility
of hybridization often complicates straightforward analysis.
Crosslinker-modified nucleic acid probes can offer an elegant way
to circumvent the pitfalls of standard hybridization-based methods
as probe-target interactions are covalently locked. However, whilst a
plethora of crosslinking agents has been designed, only few have
reached the cellular biology labs. This is mainly due to the need for
such reactions to be fast, high yielding, biocompatible and to occur
with high specificity leading to stable conjugates. Furthermore, the
crosslinking reactions should proceed in highly diluted conditions,
in presence of other biomolecules that might impede binding of
the crosslinking probe to the nucleic acid target. The occurrence of
secondary and tertiary DNA/RNA structure might further compli-
cate reaction. To date, no crosslinking agent exists that meets all
these criteria. Nevertheless, it is clear from the applications dis-
cussed in this review that hybridization-based assays can indeed
benefit from the use of crosslinking agents. Further optimization of
existing agents or the design of novel crosslinking methodologies
can help improving the general applicability of crosslinking agents
in a biological context and may eventually result in the common
use of crosslinkers in the study and detection of nucleic acids. In
this prospect, there is room for improvement in the design of new
crosslinking moieties. Indeed, the ideal crosslinker should combine
the various features of the existing agents: (1) a small size which
ensures minimal sterical hindrance in analogy with diazirines; (2) a
fast reaction which proceeds in high yield such as the vinylcarba-
zole derivatives; (3) reversible in nature like coumarin, psoralen and
vinycarbazole crosslinkers; (4) a pro-reactive moiety to ensure
selective reaction and (5) based on a moiety that can be incorpo-
rated chemically or enzymatically in oligonucleotide sequences in
analogy to thiouridines.
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